SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Local Biotechs Battle Superbugs, While Facing Business Challenges
HEALTH: Region Has Talent, Grants, And Track Record for FightIn a race to combat antibiotic resistance, big pharma bailed. Investors are skeptical. But Forge Therapeutics isn’t deterred.OncoSec’s Korean Ties Draw Attention in U.S. and S. Korea
Japan sticks out as San Diego biotech’s most valuable international trading partner. Elsewhere in Asia, regional biotechs like Tocagen are gaining a foothold in China through partnerships with Chinese firms.
StemGenex’s Marketing, Manufacturing Draw FDA Warning
StemGenex Biologic Laboratories recently drew a warning letter from the U.S. Food and Drug Administration over manufacturing practices and the marketing of an unapproved stem cell therapy.
Synthorx Files for $100M IPO
With a pipeline that activates tumor-fighting immune cells, Synthorx looks to raise $100 million through an initial public offering.
Scientist.com to Open an Office in Japan
The San Diego-based company recently experienced growth in its Japanese clientele, which includes several large pharmaceuticals.
NIH Grant Puts Wind in Kaer Biotherapeutics’ Sails
Kaer Biotherapeutics of Escondido received a $2 million grant from the National Institutes of Health to help develop a device for people who can't breathe.
Heron Therapeutics Reports Quarterly Results
San Diego-based Heron Therapeutics recently reported a quarterly loss of $38.3 million, or 49 cents per share.
San Diego Medical Device Startup Wins CES Honors
San Diego medical device startup Triple W was honored by CES for its wearable device intended to help users with urinary incontinence.
Life Sciences Show That It’s Never Too Early to Be Heard
GOVERNMENT: From Reimbursement to Education, Efforts Made
Samumed has yet to put a drug on the market, but the company wants the ear of osteoarthritis policymakers and advocacy groups.
Mirum Pharmaceuticals Launches with $120M Round
San Diego-based Mirum Pharmaceuticals surfaced Nov. 7 with a $120 million Series A round – and plans to take a liver drug candidate into final-stage clinical trials.
Dexcom Revenue Rises 44 Percent in Q3
Dexcom’s revenue and net income shot up in quarter three results after the successful launch of its G6 diabetes monitoring system.
Q3: Neurocrine Reports Rising Drug Sales
San Diego biotech Neurocrine reported $151.8 million in quarter three revenue, a 150 percent year-over-year increase.
MEI Pharma Receives $10M Up Front in Licensing Deal
San Diego-based MEI Pharma licensed its drug candidate to Japanese company Kyowa Hakko Kirin, receiving $10 million up front, with an additional $87.5 million in development milestones and sales royalties possible if the drug wins approval in Japan.
ResMed to Buy MatrixCare for $750M
Medical device company ResMed looks to expand its software-as-a-service business through a recently announced acquisition.
Illumina Aims to Increase Sequencing Dominance with $1.2B Planned Acquisition
Illumina is poised to acquire niche competitor Pacific Biosciences for $1.2 billion, a deal analysts say would fortify Illumina’s dominance in genomic sequencing.
Prev Next